The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Form 38.5b - Smurfit Kappa Group plc

5 Jun 2018 11:13

RNS Number : 3496Q
Credit Suisse Securities (Eur) Ltd
05 June 2018
 

Ap27

 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY

STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1. KEY INFORMATION

 

Name of exempt principal trader

 Credit Suisse Securities (Europe) Ltd

Company dealt in

Smurfit Kappa Group Plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary

Date of dealing

4 June 2018

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

0

0

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

0

0

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Ap28

 

 

3. DEALINGS (Note 3)

 

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit (EUR / GBp)

S

163

3,162.00

B

712

3,120.00

S

712

3,120.00

B

801

3,119.78

S

801

3,119.78

B

1602

3,119.51

S

1602

3,119.51

B

89

3,118.00

S

89

3,118.00

S

45

3,106.00

B

25

3,102.00

S

28

3,092.00

S

652

3,090.00

S

444

3,088.00

S

332

3,086.00

S

479

3,084.00

S

1407

3,082.00

B

184

3,080.00

S

800

3,080.00

B

238

3,078.00

S

286

3,074.00

S

643

3,072.00

S

229

3,070.00

B

817

3,069.96

S

1634

3,069.96

B

121

3,068.00

B

725

3,062.00

S

992

3,062.00

B

81

3,060.00

S

444

3,060.00

B

24

3,054.00

S

213

3,050.00

B

64

3,048.00

B

65

3,046.00

S

647

3,044.00

B

15

3,042.00

S

217

3,042.00

S

82

3,038.00

S

775

3,036.00

S

209

3,034.00

S

852

3,032.00

S

656

3,030.00

S

397

3,016.00

S

404

3,014.00

B

14862

3,012.63

S

416

3,012.00

S

249

3,006.00

S

750

3,004.00

B

540

2,996.68

S

540

2,996.68

S

423

2,992.00

S

659

2,988.00

S

24862

2,980.89

S

681

2,968.00

S

644

2,966.00

B

1001

2,964.53

S

1001

2,964.53

B

480

2,964.00

S

720

2,964.00

B

27100

2,962.23

S

13550

2,962.23

S

1050

2,962.00

S

922

2,960.00

B

2698

2,959.57

S

361

2,954.00

S

476

2,950.00

B

8668

2,948.05

S

8668

2,948.05

S

4334

2,947.80

S

292

2,946.00

S

777

2,944.00

S

1275

2,942.00

S

762

2,940.00

B

899

2,938.00

S

2793

2,938.00

S

448

2,936.00

B

241

2,934.00

S

1474

2,934.00

B

9131

2,932.55

B

450

2,932.00

S

888

2,932.00

S

2152

2,930.00

B

7594

2,928.61

S

7594

2,928.61

S

3797

2,928.36

B

3326

2,928.00

S

6756

2,928.00

B

461

2,926.87

S

461

2,926.87

B

252

2,926.00

S

1833

2,926.00

B

7302

2,924.15

B

396

2,924.00

S

3254

2,924.00

B

250

2,922.00

S

2227

2,922.00

S

1297

2,920.00

S

456

2,918.00

B

431

2,910.00

S

431

2,910.00

S

460

2,906.00

S

250

2,904.00

S

595

2,902.00

S

1231

2,900.00

S

2426

2,898.00

B

151

2,896.00

S

1127

2,896.00

B

19480

2,893.04

S

9740

2,893.04

B

51

2,892.11

S

34

2,892.11

S

9

2,892.00

S

963

2,890.00

S

104

2,888.00

B

389

2,886.00

S

755

2,886.00

B

530

2,884.00

S

530

2,884.00

B

2000

2,882.91

S

2000

2,882.91

S

2000

2,882.33

S

4

2,882.00

B

611

2,880.00

S

1984

2,880.00

B

24862

2,788.61

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(Note 4)

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

Ap29

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities

under any option referred to on this form or relating to the voting rights or future

acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached? (Note 8)  NO

 

 

Date of disclosure

5-June-2018

Contact name

Anthony Allen / Paul MacDonald

Telephone number

0207 888 5416 / 8548

Name of offeree/offeror with which connected

Smurfit Kappa Group Plc

Nature of connection (Note 9)

Corporate Broker to Offeree

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEBELFBVQFFBBF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.